Related Experiment Video
Updated: Sep 24, 2026
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Platelet monoamine oxidase activity in subgroups of schizophrenic disorders
Abstract:
This article summarizes findings from a series of studies that examined platelet monoamine oxidase (MAO) activity in patients with nonaffective schizophrenic disorders and schizophrenia-related depressions. The findings indicate that mean platelet MAO activity was not different from control values in the subgroup of nonaffective schizophrenic disorders without auditory hallucinations (that is, the S-1 subgroup). However, mean platelet MAO activity was reduced in the subgroup of nonaffective schizophrenic disorders characterized by the presence of auditory hallucinations often occurring in conjunction with paranoid features (that is, the S-2 subgroup). Moreover, we found that mean platelet MAO activity was increased in schizophrenia-related depressions characterized by histories of chronic asocial, eccentric, or bizarre behavior.
Insights
Platelet monoamine oxidase (MAO) activity differs in schizophrenia subtypes. Reduced MAO activity is linked to auditory hallucinations, while increased activity is associated with schizophrenia-related depressions and chronic eccentric behaviors.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Platelet monoamine oxidase (MAO) is an enzyme implicated in neurotransmitter metabolism.
- Altered MAO activity has been investigated in various psychiatric disorders, including schizophrenia.
- Understanding MAO activity in specific schizophrenia subtypes may offer diagnostic or therapeutic insights.
Purpose of the Study:
- To investigate platelet monoamine oxidase (MAO) activity in distinct subgroups of patients with nonaffective schizophrenic disorders and schizophrenia-related depressions.
- To determine if MAO activity levels correlate with specific symptom profiles, such as auditory hallucinations or chronic behavioral patterns.
Main Methods:
- Enzyme activity assays were performed on platelets from patients diagnosed with schizophrenia and related depressive disorders.
- Patients were categorized into subgroups based on the presence of auditory hallucinations, paranoid features, and histories of chronic asocial/eccentric behavior.
- Platelet MAO activity in patient subgroups was compared to control values.
Main Results:
- Mean platelet MAO activity was comparable to controls in nonaffective schizophrenic disorders without auditory hallucinations (S-1 subgroup).
- A significant reduction in mean platelet MAO activity was observed in nonaffective schizophrenic disorders with auditory hallucinations and paranoid features (S-2 subgroup).
- Mean platelet MAO activity was elevated in schizophrenia-related depressions characterized by chronic asocial, eccentric, or bizarre behaviors.
Conclusions:
- Platelet MAO activity levels vary across different clinical presentations of schizophrenia and related disorders.
- Reduced MAO activity may be associated with the presence of auditory hallucinations in schizophrenia.
- Increased MAO activity might be a biomarker for schizophrenia-related depressions with specific behavioral histories.
